Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

DNA Script builds benchtop DNA printers that synthesise custom oligonucleotides enzymatically in a laboratory rather than at a central facility. Its SYNTAX system lets researchers design and produce sequences the same day. The company is headquartered in the Paris region and also operates in the United States.

News

Award NewsMedical 2 months ago
DNA Script and leading healthcare solutions provider awarded up to $26 M by ARPA-H to advance cell-free DNA bioproduction
DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million in funding for a four-year initi
Read more
Report
News NewsMedical 3 months ago
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences
DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company's SYNTAX platform across In
Read more
Report
News labroots.com 11 months ago
DNA Script Read more
Report
Blog 1 year ago
Blog Post #4
What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type spe
Read more
Report
Blog 1 year ago
Blog Post #3
What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type spe
Read more
Report
Blog 1 year ago
Blog Post #2
What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type spe
Read more
Report
Blog 1 year ago
Blog Post #1
What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type spe
Read more
Report
Show more news

Tech stack

The technologies known for DNA Script, by layer.
Practices & domains
Antibody Engineering
CRISPR
Next-Generation Sequencing
Sign in to see how your skills match this stack Sign In

People

Sylvain Gariel
Directeur Général
Xavier Godron
Directeur Général
Marc Montserrat Litchfield
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
48/100
Stable
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Dynamics +100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Sales
50% ▼
Science & Research
50% ▼

Offices

Where the company hires and what each office is for
Cities
3
Hiring now
1
Countries
2
Busiest office
Le Kremlin-Bicêtre
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Le Kremlin-Bicêtre France
HQ
France Office
1 open roles 100% engineering 50-200 est. staff
hires for Science & Research
Registered office: Immeuble Okabé - 67, avenue de Fontainebleau, 94270 Le Kremlin-Bicêtre
seen since Nov 2023 company site, careers board, job postings
Paris France
HQ
South San Francisco United States
Regional office
US Office
careers board

Jobs

≈ $55k – $88k per year (Estimated) · In office · 5+ years exp · Master's Degree · Le Kremlin-Bicêtre
CRISPR
Next-Generation Sequencing
Antibody Engineering
Apply

Financials

Est. Annual Revenue
$8.4M
2024